Eisenmenger syndrome: diagnosis, prognosis and clinical management.

Heart
Alexandra ArvanitakiAstrid Lammers

Abstract

Eisenmenger syndrome (ES) represents the most severe phenotype of pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) and occurs in patients with large unrepaired shunts. Despite early detection of CHD and major advances in paediatric cardiac surgery, ES is still prevalent and requires a multidisciplinary approach by adult CHD experts in tertiary centres. Central cyanosis is the primary clinical manifestation leading to secondary erythrocytosis and various multiorgan complications that increase morbidity and affect quality of life. Close follow-up is needed to early diagnose and timely manage these complications. The primary goal of care is to maintain patients' fragile stability. Although the recent use of advanced PAH therapies has substantially improved functional capacity and increased life expectancy, long-term survival remains poor. Progressive heart failure, infectious diseases and sudden cardiac death comprise the main causes of death in patients with ES. Impaired exercise tolerance, decreased arterial oxygen saturation, iron deficiency, pre-tricuspid shunts, arrhythmias, increased brain natriuretic peptide, echocardiographic indices of right ventricular dysfunction and hospitalisation f...Continue Reading

References

Jun 28, 2006·Circulation·Nazzareno GalièUNKNOWN Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators
Aug 31, 2010·European Heart Journal·Helmut BaumgartnerUNKNOWN ESC Committee for Practice Guidelines (CPG)
May 25, 2011·European Heart Journal·Alexander Van De BruaeneWerner Budts
Sep 3, 2011·The European Respiratory Journal·J HurdmanD G Kiely
Aug 18, 2012·Circulation·Pamela MoceriWei Li
Jan 9, 2013·International Journal of Cardiology·Alexander Van De BruaeneWerner Budts
Jun 13, 2015·Pulmonary Circulation·Kasper KorsholmJens Erik Nielsen-Kudsk
Jul 22, 2015·Heart·George Giannakoulas, Maria Boutsikou
Feb 5, 2016·European Heart Journal·Gerhard-Paul DillerUNKNOWN German Competence Network for Congenital Heart Defects Investigators
Nov 22, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Sébastien HascoëtAndré Capderou
Apr 22, 2017·European Heart Journal·Cristel M Sørensen HjortshøjLars Søndergaard
May 20, 2017·Congenital Heart Disease·Shankar BaskarGruschen Veldtman
Jul 1, 2017·Heart·Agustin C Martin-GarciaMichael A Gatzoulis
May 4, 2018·Heart·Margarita Brida, Michael A Gatzoulis
Aug 31, 2018·European Heart Journal·Vera Regitz-ZagrosekUNKNOWN ESC Scientific Document Group
Dec 1, 2018·Journal of the American College of Cardiology·Konstantinos DimopoulosUNKNOWN CHAMPION Steering Committee
Dec 28, 2018·Circulation·Michael A GatzoulisUNKNOWN MAESTRO Study Investigators
Jan 29, 2019·Heart, Lung & Circulation·Alexandra ArvanitakiGeorge Giannakoulas
Jun 7, 2019·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Silvia GuarguagliSabine Ernst
Aug 16, 2019·The European Respiratory Journal·Michele D'AltoKonstantinos Dimopoulos
Aug 23, 2019·Heart·Cristel S HjortshøjLars Søndergaard
Oct 31, 2019·Pulmonary Circulation·Alexandra ArvanitakiUNKNOWN Hellenic Society for the Study of Pulmonary Hypertension (HSSPH)
Dec 20, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Katleen SwinnenMarion Delcroix

❮ Previous
Next ❯

Citations

Mar 21, 2021·International Journal of Cardiology·Alexandra ArvanitakiTheodoros Dimitroulas
Aug 12, 2021·European Heart Journal. Case Reports·Alexandra ArvanitakiAstrid Elisabeth Lammers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.